Anime Market to Grow at a CAGR of 9.6% from 2025 to 2032 | SkyQuest Technology Consulting

The Anime market is anticipated to increase due to rapidly expanding international fanbase, especially among Gen Z and millennials. Increased accessibility through streaming platforms and social media has fostered anime communities worldwide. SkyQuest Technology Consulting published a report, titled, Anime Market- Global Opportunity Analysis and Industry Forecast, 2025-2032″, valued at USD33.64 Billionin 2024. With a […]

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines – CNC

NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company")(NYSE:CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SRPT

NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ:SRPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reddit, Inc. of Class Action Lawsuit and Upcoming Deadlines – RDDT

NEW YORK, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Reddit, Inc. ("Reddit" or the "Company") (NYSE:RDDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines – TEM

NEW YORK, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc.â?¯("Tempus" or the "Company")(NASDAQ:TEM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comâ?¯or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vestis Corporation of Class Action Lawsuit and Upcoming Deadlines – VSTS

NEW YORK, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation ("Vestis" or the "Company") (NYSE:VSTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

Renowned Political Journalist Vassy Kapelos Joins Community Living Toronto’s Patron’s Council

TORONTO, July 30, 2025 (GLOBE NEWSWIRE) — Community Living Toronto is proud to welcome Vassy Kapelos, acclaimed political journalist and national television and radio host, as the newest member of its Patron's Council — a group of distinguished leaders who lend their influence and voice to champion the rights and inclusion of people with intellectual

Ultragenyx Pharmaceutical Inc. (RARE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or "the Company") (NASDAQ:RARE). Investors who purchased Ultragenyx securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RARE.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. – JSPR

NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jasper and certain of its officers and/or

Scroll to Top